{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:53:55Z","timestamp":1794322435856,"version":"4.9.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,14]]},"DOI":"10.7759\/cureus.9184","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T16:33:21Z","timestamp":1594744401000},"source":"Crossref","is-referenced-by-count":22,"title":["A Review of Psychiatric Comorbidity in Myasthenia Gravis"],"prefix":"10.7759","author":[{"given":"Christina","family":"Law","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire V","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sankar","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2005.02.008","article-title":"Should neurologists be trained to recognize and treat co-morbid depression of neurological disorders? Yes","volume":"6","author":"Kanner AM","year":"2005","unstructured":"Kanner AM. Should neurologists be trained to recognize and treat co-morbid depression of neurological disorders? Yes. Epilepsy Behav. 2005, 6:303-311. 10.1016\/j.yebeh.2005.02.008","journal-title":"Epilepsy Behav"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610204000845","article-title":"Unrecognized depression in community-dwelling elderly persons in Istanbul","volume":"17","author":"Kulaksizoglu IB","year":"2005","unstructured":"Kulaksizoglu IB, Gurvit H, Polat A, et al.. Unrecognized depression in community-dwelling elderly persons in Istanbul. Int Psychogeriatr. 2005, 17:303-312. 10.1017\/S1041610204000845","journal-title":"Int Psychogeriatr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2003.08.018","article-title":"The impact of mood disorders in neurological diseases: should neurologists be concerned?","volume":"4","author":"Kanner AM","year":"2003","unstructured":"Kanner AM, Barry JJ. The impact of mood disorders in neurological diseases: should neurologists be concerned?. Epilepsy Behav. 2003, 4:3-13. 10.1016\/j.yebeh.2003.08.018","journal-title":"Epilepsy Behav"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.7.979","article-title":"The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey","volume":"151","author":"Blazer DG","year":"1994","unstructured":"Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry. 1994, 151:979-986. 10.1176\/ajp.151.7.979","journal-title":"Am J Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States","volume":"51","author":"Kessler RC","year":"1994","unstructured":"Kessler RC, McGonagle KA, Zhao S, et al.. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry. 1994, 51:8-19. 10.1001\/archpsyc.1994.03950010008002","journal-title":"Arch Gen Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.8.976","article-title":"Psychiatric disorder in a sample of the general population with and without chronic medical conditions","volume":"145","author":"Wells KB","year":"1988","unstructured":"Wells KB, Golding JM, Burnam MA. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry. 1988, 145:976-981. 10.1176\/ajp.145.8.976","journal-title":"Am J Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1988.tb05148.x","article-title":"Psychiatric disturbances associated with myasthenia gravis","volume":"77","author":"Magni G","year":"1988","unstructured":"Magni G, Micaglio GF, Lalli R,  Bejato L, Candeago MR, Merskey H, Angelini C. Psychiatric disturbances associated with myasthenia gravis. Acta Psychiatr Scand. 1988, 77:443-445. 10.1111\/j.1600-0447.1988.tb05148.x","journal-title":"Acta Psychiatr Scand"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-8-129","article-title":"Quality of life and life circumstances in German myasthenia gravis patients","volume":"8","author":"Twork S","year":"2010","unstructured":"Twork S, Wiesmeth S, Klewer J, Pohlau D, Kugler J. Quality of life and life circumstances in German myasthenia gravis patients. Health Qual Life Outcomes. 2010, 8:129. 10.1186\/1477-7525-8-129","journal-title":"Health Qual Life Outcomes"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9367453","article-title":"Prevalence and associated factors of depressive symptoms in patients with myasthenia gravis: a cross-sectional study of two tertiary hospitals in Riyadh, Saudi Arabia","volume":"2019","author":"Alanazy MH","year":"2019","unstructured":"Alanazy MH. Prevalence and associated factors of depressive symptoms in patients with myasthenia gravis: a cross-sectional study of two tertiary hospitals in Riyadh, Saudi Arabia. Behav Neurol. 2019, 2019:9367453. 10.1155\/2019\/9367453","journal-title":"Behav Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206754","article-title":"Factors associated with quality of life of people with myasthenia gravis","volume":"13","author":"Jeong A","year":"2018","unstructured":"Jeong A, Min JH, Kang YK, Kim J, Choi M, Seok JM, Kim BJ. Factors associated with quality of life of people with myasthenia gravis. PLoS One. 2018, 13:0206754. 10.1371\/journal.pone.0206754","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-282X2011000200006","article-title":"Psychiatric disorders in myasthenia gravis","volume":"69","author":"Ybarra MI","year":"2011","unstructured":"Ybarra MI, Kummer A, Frota ER, Oliveira JT, Gomez RS, Teixeira AL. Psychiatric disorders in myasthenia gravis. Arq Neuropsiquiatr. 2011, 69:176-179. 10.1590\/S0004-282X2011000200006","journal-title":"Arq Neuropsiquiatr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.12.4.499","article-title":"Severity of mood, self-explorative and vegetative symptoms of depression in myasthenia gravis","volume":"12","author":"Paul RH","year":"2000","unstructured":"Paul RH, Cohen RA, Goldstein JM, Gilchrist JM. Severity of mood, self-explorative and vegetative symptoms of depression in myasthenia gravis. J Neuropsychiatry Clin Neurosci. 2000, 12:499-501. 10.1176\/jnp.12.4.499","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-012-1170-2","article-title":"Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia)","volume":"33","author":"Basta IZ","year":"2012","unstructured":"Basta IZ, Pekmezovic TD, Peric SZ, Kisi\u0107-Tepav\u010devi\u0107 DB, Rako\u010devi\u0107-Stojanovi\u0107 VM, Stevi\u0107 ZD, Lavrni\u0107 DV. Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia). Neurol Sci. 2012, 33:1375-1381. 10.1007\/s10072-012-1170-2","journal-title":"Neurol Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2015.01.022","article-title":"Clinical features and impact of myasthenia gravis disease in Australian patients","volume":"22","author":"Blum S","year":"2015","unstructured":"Blum S, Lee D, Gillis D, McEniery DF, Reddel S, McCombe P. Clinical features and impact of myasthenia gravis disease in Australian patients. J Clin Neurosci. 2015, 22:1164-1169. 10.1016\/j.jocn.2015.01.022","journal-title":"J Clin Neurosci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1037\/0278-6133.14.1.88","article-title":"Major depression and medication adherence in elderly patients with coronary artery disease","volume":"14","author":"Carney RM","year":"1995","unstructured":"Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol. 1995, 14:88-90. 10.1037\/0278-6133.14.1.88","journal-title":"Health Psychol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(81)90599-7","article-title":"Influence of psychosocial factors on survival of home-dialysis patients","volume":"2","author":"Wai L","year":"1981","unstructured":"Wai L, Richmond J, Burton H, Lindsay RM. Influence of psychosocial factors on survival of home-dialysis patients. Lancet. 1981, 2:1155-1156. 10.1016\/s0140-6736(81)90599-7","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(02)00313-6","article-title":"The impact of major depression on chronic medical illness","volume":"53","author":"Katon W","year":"2002","unstructured":"Katon W, Ciechanowski P. The impact of major depression on chronic medical illness. J Psychosom Res. 2002, 53:859-863. 10.1016\/S0022-3999(02)00313-6","journal-title":"J Psychosom Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.11.1351","article-title":"The NIMH depression awareness, recognition and treatment program structure, aims, and scientific basis","volume":"145","author":"Regier DA","year":"1988","unstructured":"Regier DA, Hirschfeld RM, Goodwin FK, Burke JD Jr, Lazar JB, Judd LL. The NIMH depression awareness, recognition and treatment program structure, aims, and scientific basis. Am J Psychiatry. 1988, 145:1351-1357. 10.1176\/ajp.145.11.1351","journal-title":"Am J Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1995.03950220060012","article-title":"Health care costs of primary care patients with recognized depression","volume":"52","author":"Simon GE","year":"1995","unstructured":"Simon GE, VonKorff M, Barlow W. Health care costs of primary care patients with recognized depression. Arch Gen Pscyhiatry. 1995, 52:850-856. 10.1001\/archpsyc.1995.03950220060012","journal-title":"Arch Gen Pscyhiatry"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1995.tb07002.x","article-title":"Neuropsychological test performance and affect in myasthenia gravis","volume":"91","author":"Bartel PR","year":"1995","unstructured":"Bartel PR, Lotz BP. Neuropsychological test performance and affect in myasthenia gravis. Acta Neurol Scand. 1995, 91:266-270. 10.1111\/j.1600-0404.1995.tb07002.x","journal-title":"Acta Neurol Scand"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s100720100066","article-title":"Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements","volume":"22","author":"Padua L","year":"2001","unstructured":"Padua L, Evoli A, Aprile I, et al.. Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements. Neurol Sci. 2001, 22:363-369. 10.1007\/s100720100066","journal-title":"Neurol Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01149.x","article-title":"Correlation between regional myasthenic weakness and mental aspects of quality of life","volume":"13","author":"Rostedt A","year":"2006","unstructured":"Rostedt A, Padua L, Stalberg EV. Correlation between regional myasthenic weakness and mental aspects of quality of life. Eur J Neurol. 2006, 13:191-193. 10.1111\/j.1468-1331.2006.01149.x","journal-title":"Eur J Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.7.1102","article-title":"Anxiety disorders in a neuromuscular clinic","volume":"150","author":"Paradis CM","year":"1993","unstructured":"Paradis CM, Friedman S, Lazar RM, Kula RW. Anxiety disorders in a neuromuscular clinic. Am J Psychiatry. 1993, 150:1102-1104. 10.1176\/ajp.150.7.1102","journal-title":"Am J Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-009-0167-y","article-title":"Concordance between severity of disease, disability and health-related quality of life in myasthenia gravis","volume":"31","author":"Raggi A","year":"2010","unstructured":"Raggi A, Leonardi M, Antozzi C, Confalonieri P, Maggi L, Cornelio F, Mantegazza R. Concordance between severity of disease, disability and health-related quality of life in myasthenia gravis. Neurol Sci. 2010, 31:41-45. 10.1007\/s10072-009-0167-y","journal-title":"Neurol Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200721060-00004","article-title":"Mood and anxiety disorders in patients with myasthenia gravis: aetiology, diagnosis and treatment","volume":"21","author":"Kulaksizoglu IB","year":"2007","unstructured":"Kulaksizoglu IB. Mood and anxiety disorders in patients with myasthenia gravis: aetiology, diagnosis and treatment. CNS Drugs. 2007, 21:473-481. 10.2165\/00023210-200721060-00004","journal-title":"CNS Drugs"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-5913-4","article-title":"Psychosocial aspects in myasthenic patients treated by plasmapheresis","volume":"258","author":"Chen YT","year":"2011","unstructured":"Chen YT, Chang Y, Chiu HC, Yeh JH. Psychosocial aspects in myasthenic patients treated by plasmapheresis. J Neurol. 2011, 258:1240-1246. 10.1007\/s00415-011-5913-4","journal-title":"J Neurol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002828","article-title":"Preoperative anxiety in patients with myasthenia gravis and risk for myasthenic crisis after extended transsternal thymectomy: a CONSORT study","volume":"95","author":"Zou J","year":"2016","unstructured":"Zou J, Su C, Lun X, et al.. Preoperative anxiety in patients with myasthenia gravis and risk for myasthenic crisis after extended transsternal thymectomy: a CONSORT study. Medicine (Baltimore). 2016, 95:2828. 10.1097\/MD.0000000000002828","journal-title":"Medicine (Baltimore)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2011-000313","article-title":"Factors associated with depressive state in patients with myasthenia gravis: a multicenter cross-sectional study","volume":"1","author":"Suzuki Y","year":"2011","unstructured":"Suzuki Y, Utsugisawa K, Suzuki S, et al.. Factors associated with depressive state in patients with myasthenia gravis: a multicenter cross-sectional study. BMJ Open. 2011, 1:000313. 10.1136\/bmjopen-2011-000313","journal-title":"BMJ Open"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(99)00007-4","article-title":"Effects of acute prednisone administration on memory, attention, and emotion in healthy human adults","volume":"24","author":"Schmidt LA","year":"1999","unstructured":"Schmidt LA, Fox NA, Goldberg MC, Smith CC, Schulkin J. Effects of acute prednisone administration on memory, attention, and emotion in healthy human adults. Psychoneuroimmunol. 1999, 24:461-483. 10.1016\/S0306-4530(99)00007-4","journal-title":"Psychoneuroimmunol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1515\/REVNEURO.2004.15.2.109","article-title":"Corticosteroids, depression and the role of serotonin","volume":"15","author":"Pretorius E","year":"2004","unstructured":"Pretorius E. Corticosteroids, depression and the role of serotonin. Rev Neurosci. 2004, 15:109-116. 10.1515\/REVNEURO.2004.15.2.109","journal-title":"Rev Neurosci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.4065\/81.10.1361","article-title":"Psychiatric adverse effects of corticosteroids","volume":"81","author":"Warrington TP","year":"2006","unstructured":"Warrington TP, Botswick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006, 81:1361-1367. 10.4065\/81.10.1361","journal-title":"Mayo Clin Proc"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2007.01.001","article-title":"Therapeutic options in autoimmune myasthenia gravis","volume":"6","author":"Garcia-Carrasco M","year":"2007","unstructured":"Garcia-Carrasco M, Escarcega RO, Fuentes-Alexandro S, Riebeling C, Cercera R. Therapeutic options in autoimmune myasthenia gravis. Autoimmune Rev. 2007, 6:373-378. 10.1016\/j.autrev.2007.01.001","journal-title":"Autoimmune Rev"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5279-z","article-title":"The relationship between health, disability and quality of life in myasthenia gravis: results from an Italian study","volume":"257","author":"Leonardi M","year":"2010","unstructured":"Leonardi M, Raggi A, Antozzi C, Confalonieri P, Maggi L, Cornelio F, Mantegazza R. The relationship between health, disability and quality of life in myasthenia gravis: results from an Italian study. J Neurol. 2010, 257:98-102. 10.1007\/s00415-009-5279-z","journal-title":"J Neurol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-009-0194-8","article-title":"Social support and self-efficacy in patients with myasthenia gravis: a common pathway towards positive health outcomes","volume":"31","author":"Raggi A","year":"2009","unstructured":"Raggi A, Leonardi M, Mantegazza R, Casale S, Fioravanti G. Social support and self-efficacy in patients with myasthenia gravis: a common pathway towards positive health outcomes. Neurol Sci. 2009, 31:41-45. 10.1007\/s10072-009-0194-8","journal-title":"Neurol Sci"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3109\/00207454.2015.1038712","article-title":"Quality of life in 188 patients with myasthenia gravis in China","volume":"126","author":"Yang Y","year":"2016","unstructured":"Yang Y, Zhang M, Guo J, et al.. Quality of life in 188 patients with myasthenia gravis in China. Int J Neurosci. 2016, 126:455-462. 10.3109\/00207454.2015.1038712","journal-title":"Int J Neurosci"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14057","article-title":"Chronic stress, depression and personality type in patients with myasthenia gravis","volume":"27","author":"Bogdan A","year":"2020","unstructured":"Bogdan A, Barnett C, Ali A, AlQwaifly M, Abraham A, Mannan S, Ng E, Bril V. Chronic stress, depression and personality type in patients with myasthenia gravis. Eur J Neurol. 2020, 27:204-209. 10.1111\/ene.14057","journal-title":"Eur J Neurol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(80)92776-2","article-title":"Myasthenia gravis: a study of social, medical and emotional problems in 26 patients","volume":"1","author":"Sneddon J","year":"1980","unstructured":"Sneddon J. Myasthenia gravis: a study of social, medical and emotional problems in 26 patients. Lancet. 1980, 1:526-528. 10.1016\/s0140-6736(80)92776-2","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(98)00012-1","article-title":"Fluoxetine treatment for weight reduction in steroid-induced obesity: a pilot study in myasthenia gravis patients","volume":"9","author":"Achiron A","year":"1999","unstructured":"Achiron A, Barak Y, Noy S, Pinhas-Hamiel O. Fluoxetine treatment for weight reduction in steroid-induced obesity: a pilot study in myasthenia gravis patients. Eur Neuropsychopharmacol. 1999, 9:111-113. 10.1016\/S0924-977X(98)00012-1","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(71)90043-9","article-title":"Psychopathology associated with myasthenia gravis and its treatment by psychotherapeutically oriented group counseling","volume":"24","author":"Schwartz ML","year":"1971","unstructured":"Schwartz ML, Cahill R. Psychopathology associated with myasthenia gravis and its treatment by psychotherapeutically oriented group counseling. J Chron Dis. 1971, 24:543-552. 10.1016\/0021-9681(71)90043-9","journal-title":"J Chron Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197908233010805","article-title":"Disorders of neuromuscular transmission caused by drugs","volume":"30","author":"Argov Z","year":"1979","unstructured":"Argov Z, Mastaglia FL. Disorders of neuromuscular transmission caused by drugs. N Engl J Med. 1979, 30:409-413. 10.1056\/NEJM197908233010805","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1053\/smrv.2000.0122","article-title":"Hypnotic medication in the treatment of chronic insomnia: non nocere! Doesn\u2019t anyone care?","volume":"4","author":"Kramer M","year":"2000","unstructured":"Kramer M. Hypnotic medication in the treatment of chronic insomnia: non nocere! Doesn\u2019t anyone care?. Sleep Med Rev. 2000, 4:529-541. 10.1053\/smrv.2000.0122","journal-title":"Sleep Med Rev"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770090080007","article-title":"Emergence of myasthenia gravis during treatment with lithium carbonate","volume":"33","author":"Neil JF","year":"1976","unstructured":"Neil JF, Himmelhoch JM, Licata SM. Emergence of myasthenia gravis during treatment with lithium carbonate. Arch Gen Psychiatry. 1976, 33:1090-1092. 10.1001\/archpsyc.1976.01770090080007","journal-title":"Arch Gen Psychiatry"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.01.002","article-title":"Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology","volume":"36","author":"Hehir","year":"2018","unstructured":"Hehir, MK, Silvestri NJ. Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology. Neurol Clin. 2018, 36:253-260. 10.1016\/j.ncl.2018.01.002","journal-title":"Neurol Clin"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013278","article-title":"Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study","volume":"7","author":"Nagane Y","year":"2017","unstructured":"Nagane Y, Murai H, Imai T, et al.. Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study. BMJ Open. 2017, 7:013278. 10.1136\/bmjopen-2016-013278","journal-title":"BMJ Open"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5256-6","article-title":"Socioeconomic burden of Amytrophic lateral sclerosis, myasthenia gravis and fascioscapulohumeral muscular dystrophy","volume":"257","author":"Schepelmann K","year":"2010","unstructured":"Schepelmann K, Winter Y, Spottke AE, et al.. Socioeconomic burden of Amytrophic lateral sclerosis, myasthenia gravis and fascioscapulohumeral muscular dystrophy. J Neurol. 2010, 257:15-23. 10.1007\/s00415-009-5256-6","journal-title":"J Neurol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/mus.22212","article-title":"Cost analysis of myasthenia gravis from a large U.S. insurance database","volume":"44","author":"Guptill. JT","year":"2011","unstructured":"Guptill. JT, Marano A, Krueger A, Sanders DB. Cost analysis of myasthenia gravis from a large U.S. insurance database. Muscle Nerve. 2011, 44:907-911. 10.1002\/mus.22212","journal-title":"Muscle Nerve"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in myasthenia gravis","volume":"10","author":"Carr AS","year":"2010","unstructured":"Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol. 2010, 10:46. 10.1186\/1471-2377-10-46","journal-title":"BMC Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/33676-a-review-of-psychiatric-comorbidity-in-myasthenia-gravis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:19:25Z","timestamp":1707506365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/33676-a-review-of-psychiatric-comorbidity-in-myasthenia-gravis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":47,"URL":"https:\/\/doi.org\/10.7759\/cureus.9184","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,14]]}}}